David Jobes, PhD, advises seqSight on business development, partnerships, financing, and transaction strategy. He is a life sciences executive with more than 25 years of experience across biotechnology, health care, and pharmaceuticals. As co-founder and president of Mid-Atlantic BioTherapeutics and co-founder of several biotechnology companies, he has participated in more than $500 million in buy-side and sell-side transactions. He holds a PhD in Cell and Molecular Biology and completed postdoctoral research at the NIH. At seqSight he helps structure paid pilots, enterprise pricing, channel partnerships, and financing.